The National Institutes of Health, more commonly known as NIH, is a government agency operating within the United States Department of Health and Human Services that's essentially responsible for ensuring and supporting all of the country's biomedical and health-related research studies.
The grants and programs of the NIH are all designed to contribute to the achievement of its overall agency mission which is to "seek basic knowledge of the nature and behaviour of living systems and the application of that information to enhance health, lengthen life, and scale back the burdens of illness and disability."
In accordance with this mission, the National Institutes of Health has formed a collaboration with the National Institute of Neurological Disorders and Stroke (NINDS) to develop the Exploratory Clinical Trials for Small Business Grant Program whereby they aim to build a vehicle for Small Business Concerns (SBCs) in the process of submitting Small Business Technology Transfer (STTR) grant applications for exploratory clinical trials directly to the NINDS.
The NIH and NINDS have stated that the trials and research studies that'll be funded under this program are the ones that are focusing on products that are associated to the goals and missions of the NINDS, for example an evaluation of drugs, biologics, devices, or diagnostics, and even surgical, behaviour or rehabilitation treatments.
Essentially, the Exploratory Clinical Trials for Small Business Grant Program has been established to help relieve or exterminate the responsibility that is experienced by people who are suffering from neurological disorders.
That said , the NINDS seeks to provide support to small businesses in their quest to develop emerging technologies that will potentially be of use to the objective in focus.
The examples of the types of studies that'll be supported under this programme are those that aim to:
a) Appraise and optimize the dose, formulation, safety, tolerability/pharmacokinetics of a certain intervention or diagnostic test in healthy volunteers or the target population
b) Potential clinical verification of a diagnosis
c) Asses whether or not an intervention produces sufficient evidence of short-term activity in a human "proof of concept" trial
d) Decide the best of several potential interventions or dosing programmes that'll be evaluated in a subsequent trial, based primarily on tolerability, biological activity, or initial clinical efficiency.
The NIH and NINDS are set to administer a funding amount of $750,000 per grant awardee to support the execution of this program.
The institutions and organizations who will be considered able to submit an application under this programme are those Small Business Concerns that meet the following criteria:
a) SBCs that are mainly arranged for profit and is located and operating in the US, and makes an important contribution to the United States economy through payment of taxes or use of American products, materials or labor;
b) SBCs that are in the legal form of an individual proprietorship, partnership, limited liability firm, enterprise, collaboration, organisation, trust or cooperative;
c) SBCs that more than 500 employees
d) SBSs that are at least 51% owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States.
The grants and programs of the NIH are all designed to contribute to the achievement of its overall agency mission which is to "seek basic knowledge of the nature and behaviour of living systems and the application of that information to enhance health, lengthen life, and scale back the burdens of illness and disability."
In accordance with this mission, the National Institutes of Health has formed a collaboration with the National Institute of Neurological Disorders and Stroke (NINDS) to develop the Exploratory Clinical Trials for Small Business Grant Program whereby they aim to build a vehicle for Small Business Concerns (SBCs) in the process of submitting Small Business Technology Transfer (STTR) grant applications for exploratory clinical trials directly to the NINDS.
The NIH and NINDS have stated that the trials and research studies that'll be funded under this program are the ones that are focusing on products that are associated to the goals and missions of the NINDS, for example an evaluation of drugs, biologics, devices, or diagnostics, and even surgical, behaviour or rehabilitation treatments.
Essentially, the Exploratory Clinical Trials for Small Business Grant Program has been established to help relieve or exterminate the responsibility that is experienced by people who are suffering from neurological disorders.
That said , the NINDS seeks to provide support to small businesses in their quest to develop emerging technologies that will potentially be of use to the objective in focus.
The examples of the types of studies that'll be supported under this programme are those that aim to:
a) Appraise and optimize the dose, formulation, safety, tolerability/pharmacokinetics of a certain intervention or diagnostic test in healthy volunteers or the target population
b) Potential clinical verification of a diagnosis
c) Asses whether or not an intervention produces sufficient evidence of short-term activity in a human "proof of concept" trial
d) Decide the best of several potential interventions or dosing programmes that'll be evaluated in a subsequent trial, based primarily on tolerability, biological activity, or initial clinical efficiency.
The NIH and NINDS are set to administer a funding amount of $750,000 per grant awardee to support the execution of this program.
The institutions and organizations who will be considered able to submit an application under this programme are those Small Business Concerns that meet the following criteria:
a) SBCs that are mainly arranged for profit and is located and operating in the US, and makes an important contribution to the United States economy through payment of taxes or use of American products, materials or labor;
b) SBCs that are in the legal form of an individual proprietorship, partnership, limited liability firm, enterprise, collaboration, organisation, trust or cooperative;
c) SBCs that more than 500 employees
d) SBSs that are at least 51% owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States.
About the Author:
Iola Bonggay is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs.
She also maintains Websites providing resources on environmental grants and grants for youth programs.
She also maintains Websites providing resources on environmental grants and grants for youth programs.
No comments:
Post a Comment